These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 23744127)

  • 1. Imaging of early modification in cardiomyopathy: the doxorubicin-induced model.
    Aissiou M; Périé D; Cheriet F; Dahdah NS; Laverdière C; Curnier D
    Int J Cardiovasc Imaging; 2013 Oct; 29(7):1459-76. PubMed ID: 23744127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. To study the usefulness and comparison of myocardial strain imaging by 2D and 3D echocardiography for early detection of cardiotoxicity in patients undergoing cardiotoxic chemotherapy.
    Alam S; Chandra S; Saran M; Chaudhary G; Sharma A; Bhandhari M; Vishwakarma P; Pradhan A; Sethi R; Dwivedi SK; Narain VS
    Indian Heart J; 2019; 71(6):468-475. PubMed ID: 32248920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appraising cardiotoxicity associated with liposomal doxorubicin by means of tissue Doppler echocardiography end-points: rationale and design of the LITE (Liposomal doxorubicin-Investigational chemotherapy-Tissue Doppler imaging Evaluation) randomized pilot study.
    Lotrionte M; Palazzoni G; Natali R; Comerci G; Abbate A; Di Persio S; Biondi-Zoccai GG
    Int J Cardiol; 2009 Jun; 135(1):72-7. PubMed ID: 18572266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strain Analysis in the Assessment of a Mouse Model of Cardiotoxicity due to Chemotherapy: Sample for Preclinical Research.
    Rea D; Coppola C; Barbieri A; Monti MG; Misso G; Palma G; Bimonte S; Zarone MR; Luciano A; Liccardo D; Maiolino P; Cittadini A; Ciliberto G; Arra C; Maurea N
    In Vivo; 2016; 30(3):279-90. PubMed ID: 27107087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac magnetic resonance imaging for the assessment of the myocardium after doxorubicin-based chemotherapy.
    Lunning MA; Kutty S; Rome ET; Li L; Padiyath A; Loberiza F; Bociek RG; Bierman PJ; Vose JM; Armitage JO; Porter TR
    Am J Clin Oncol; 2015 Aug; 38(4):377-81. PubMed ID: 24192805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evaluation of doxorubicin-induced cardiotoxicity: comparison of Doppler and tissue Doppler-derived myocardial performance index.
    Ayhan SS; Özdemir K; Kayrak M; Bacaksiz A; Vatankulu MA; Eren Ö; Koc F; Duman C; Gülec H; Demir K; Ari H; Sönmez O; Gök H
    Cardiol J; 2012; 19(4):363-8. PubMed ID: 22825896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of tests for monitoring doxorubicin-induced cardiomyopathy.
    Ganz WI; Sridhar KS; Ganz SS; Gonzalez R; Chakko S; Serafini A
    Oncology; 1996; 53(6):461-70. PubMed ID: 8960141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat Model of Cardiotoxic Drug-Induced Cardiomyopathy.
    Nakahara T; Tanimoto T; Petrov AD; Ishikawa K; Strauss HW; Narula J
    Methods Mol Biol; 2018; 1816():221-232. PubMed ID: 29987823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute cardiomyopathy following a single dose of doxorubicin in a patient with adult T-Cell leukemia/lymphoma.
    Farina K; Kalac M; Kim S
    J Oncol Pharm Pract; 2021 Jun; 27(4):1011-1015. PubMed ID: 32869692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adriamycin-induced myocardial toxicity: new solutions for an old problem?
    Outomuro D; Grana DR; Azzato F; Milei J
    Int J Cardiol; 2007 Apr; 117(1):6-15. PubMed ID: 16863672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies.
    Octavia Y; Tocchetti CG; Gabrielson KL; Janssens S; Crijns HJ; Moens AL
    J Mol Cell Cardiol; 2012 Jun; 52(6):1213-25. PubMed ID: 22465037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart rate dynamics in doxorubicin-induced cardiomyopathy.
    Lončar-Turukalo T; Vasić M; Tasić T; Mijatović G; Glumac S; Bajić D; Japunžić-Žigon N
    Physiol Meas; 2015 Apr; 36(4):727-39. PubMed ID: 25798626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin cardiomyopathy.
    Chatterjee K; Zhang J; Honbo N; Karliner JS
    Cardiology; 2010; 115(2):155-62. PubMed ID: 20016174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin-induced cardiomyopathy 17 years after chemotherapy.
    Kumar S; Marfatia R; Tannenbaum S; Yang C; Avelar E
    Tex Heart Inst J; 2012; 39(3):424-7. PubMed ID: 22719160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms and management of doxorubicin cardiotoxicity.
    Shi Y; Moon M; Dawood S; McManus B; Liu PP
    Herz; 2011 Jun; 36(4):296-305. PubMed ID: 21656050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Changes in Myocardial Mechanics Detected by 3-Dimensional Speckle Tracking Echocardiography in Patients Treated With Low Doses of Anthracyclines.
    Piveta RB; Rodrigues ACT; Vieira MLC; Fischer CH; Afonso TR; Daminello E; Cruz FM; Galvão TFG; Katz M; Morhy SS
    JACC Cardiovasc Imaging; 2018 Nov; 11(11):1729-1731. PubMed ID: 29909102
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiotoxic Effects of Short-Term Doxorubicin Administration: Involvement of Connexin 43 in Calcium Impairment.
    Pecoraro M; Rodríguez-Sinovas A; Marzocco S; Ciccarelli M; Iaccarino G; Pinto A; Popolo A
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29019935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for
    Chakouri N; Farah C; Matecki S; Amedro P; Vincenti M; Saumet L; Vergely L; Sirvent N; Lacampagne A; Cazorla O
    Theranostics; 2020; 10(18):8130-8142. PubMed ID: 32724462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel approach to early detection of doxorubicin cardiotoxicity by gadolinium-enhanced cardiovascular magnetic resonance imaging in an experimental model.
    Lightfoot JC; D'Agostino RB; Hamilton CA; Jordan J; Torti FM; Kock ND; Jordan J; Workman S; Hundley WG
    Circ Cardiovasc Imaging; 2010 Sep; 3(5):550-8. PubMed ID: 20622140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistance.
    Gyöngyösi M; Lukovic D; Zlabinger K; Spannbauer A; Gugerell A; Pavo N; Traxler D; Pils D; Maurer G; Jakab A; Riesenhuber M; Pircher A; Winkler J; Bergler-Klein J
    Cardiovasc Res; 2020 Apr; 116(5):970-982. PubMed ID: 31346605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.